Clinical Trial Update: A Randomized, Controlled, Double-masked, Investigator-initiated Trial to Evaluate Tear Film Quality and Stability in Subjects With Dry Eye Disease Using OC-01 (Varenicline Solution) Nasal Spray 0.03 mg as Compared to Vehicle Control Nasal Spray [Phase 4]

View source ↗

Summary

A Phase 4 randomized, double-masked, investigator-initiated trial evaluating tear film quality and stability in dry eye disease using OC-01 (varenicline) nasal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• OC-01 (varenicline) nasal spray 0.03 mg (varenicline)

Snippet

Sponsor: Stephenson Eye Associates | Conditions: Dry Eye Disease | Phase 4 | Status: UNKNOWN